Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia

NCT00924170 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

18

Enrollment

NIH

Sponsor class

Conditions

Adult T-Cell Leukemia (ATL)

Interventions

DRUG: LMB-2
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

National Cancer Institute (NCI)